Page last updated: 2024-09-04

resiquimod and Ascites

resiquimod has been researched along with Ascites in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ahmed, AA; Attard Montalto, S; Brencicova, E; Diebold, SS; Evans, HG; Georgouli, M; Jagger, AL; Laios, A; Mehra, G; Raju-Kankipati, S; Spencer, J; Taams, LS	1

Other Studies

1 other study(ies) available for resiquimod and Ascites

Article	Year
Interleukin-10 and prostaglandin E2 have complementary but distinct suppressive effects on Toll-like receptor-mediated dendritic cell activation in ovarian carcinoma. PloS one, 2017, Volume: 12, Issue:4 Topics: Antibodies, Neutralizing; Ascites; B7-2 Antigen; Cells, Cultured; Dendritic Cells; Dinoprostone; Female; Humans; Imidazoles; Interleukin-10; Interleukin-12; Interleukin-6; Lipopolysaccharides; Lymphocyte Activation; Monocytes; Ovarian Neoplasms; Poly I-C; T-Lymphocytes; Toll-Like Receptors; Tumor Necrosis Factor-alpha; Up-Regulation	2017

Article

Year

Interleukin-10 and prostaglandin E2 have complementary but distinct suppressive effects on Toll-like receptor-mediated dendritic cell activation in ovarian carcinoma.

PloS one, 2017, Volume: 12, Issue:4

Topics: Antibodies, Neutralizing; Ascites; B7-2 Antigen; Cells, Cultured; Dendritic Cells; Dinoprostone; Female; Humans; Imidazoles; Interleukin-10; Interleukin-12; Interleukin-6; Lipopolysaccharides; Lymphocyte Activation; Monocytes; Ovarian Neoplasms; Poly I-C; T-Lymphocytes; Toll-Like Receptors; Tumor Necrosis Factor-alpha; Up-Regulation

2017